Xenon XE-129, Hyperpolarized
CAS 13965-99-6Small Molecule
Overview
Xenon XE-129, Hyperpolarized is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4594411).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Xenon XE-129, Hyperpolarized expires 29 Dec 2035 and exclusivity 23 Dec 2027. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- xenon-129
- Canonical SMILES
- [129Xe]
- InChIKey
- FHNFHKCVQCLJFQ-YPZZEJLDSA-N
Verified Supplier Partner
Do you supply Xenon XE-129, Hyperpolarized? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.